Medisafe, a Boston, MA-based personalized medication management platform, raised a $14.5M Series B funding.
The round was led by Octopus Ventures, with participation from M Ventures, Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures.
The company intends to use the funds to increase sales, marketing and engineering staff and open European office.
Led by Omri Shor, CEO and co-founder, Medisafe provides a personalized medication management platform addressing all major causes of non-adherence. Its cloud-based mobile platform personalizes content, resources and interventions — such as educational videos, coupons and motivational messages — based on each user’s regimen, condition and specific circumstance.
It has been used by over three and a half million patient and caregiver registered users who have recorded over 500 million medication doses on their iOS and Android smartphones and tablets and contributed 140,000 reviews in the App Store and Google Play app stores.